Short report: octreotide in the treatment of external pancreatic fistulas.

Aliment Pharmacol Ther

Department of Medicine, Semmelweis University, Medical School, Budapest, Hungary.

Published: June 1993

The efficacy of the long-lasting somatostatin analogue, octreotide, in the treatment of high-output pancreatic fistulas was investigated in this prospective, open study. Sixteen patients with post-operative pancreatic fistulas were treated with subcutaneous injections of octreotide 0.1 mg b.d. The output of the fistulas before the somatostatin therapy ranged between 190 and 570 ml/day. The therapy was begun on average 17 days following the appearance of the fistula (range 4 to 35 days). The decrease in volume one day after initiation of therapy ranged from 26% to 69%. By the third day of treatment the fistula volume decreased to 0-45% of the initial output. The treatment resulted in the closure of 14 of the 16 fistulas; the time to closure ranging from 3 to 15 days. The results suggest that octreotide is a useful adjuvant agent in the treatment of an external pancreatic fistula.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2036.1993.tb00104.xDOI Listing

Publication Analysis

Top Keywords

pancreatic fistulas
12
octreotide treatment
8
treatment external
8
external pancreatic
8
therapy ranged
8
treatment
5
fistulas
5
short report
4
octreotide
4
report octreotide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!